Global Histrelin Market
Global Histrelin Market

Histrelin Comprehensive Study by End Use (Hospitals, Specialty Clinics), Distribution (Hospital Dispensaries, Online Third-Party Sales), End User (Male, Female) Players and Region - Global Market Outlook to 2026

Histrelin Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Aug 2021 Edition 232 Pages 213 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Histrelin Market Scope
Central Precious Puberty (CPP) is a disorder that causes children to begin puberty too early, resulting in faster than normal bone growth and development of sexual features. Histrelin is a gonadotropin releasing hormone (GnRH) agonist that inhibits testosterone (in men) and oestrogen (in women) production and is primarily used to treat metastatic prostate cancer. Histrelin hydrogel implant is a biocompatible, flexible, nonbiodegradable device containing histrelin acetate. It maintains its form and concentration gradient across its microporous walls, ensuring continual histrelin release. The histrelin implant is used to treat children who have CPP. The implant is placed subcutaneously in the inner aspect of the upper arm and releases histrelin acetate continuously throughout the treatment.

The Histrelin market study is segmented and major geographies with country level break-up.

The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Histrelin market throughout the predicted period.

Endo International plc (United States) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AMA Research has segmented the market of Global Histrelin market by Type, Application and Region.

On the basis of geography, the market of Histrelin has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Market Trend
  • High Investment in Pharmaceutical R&D

Market Drivers
  • Prevalence of Central Precocious Puberty (CCP)

Opportunities
  • Growth In Healthcare Infrastructure

Restraints
  • Side Effects and Adverse Reactions
  • Lack of Skilled Professionals

Challenges
  • Market Penetration Across New Regions
  • Regulatory Approval


Key Target Audience
Histrelin Manufactures, New Entrants and Investors, Histrelin Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Frequently Asked Questions (FAQ):

1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.

2. How big is the Histrelin Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.

Report Objectives / Segmentation Covered
By End Use
  • Hospitals
  • Specialty Clinics

By Distribution
  • Hospital Dispensaries
  • Online Third-Party Sales

By End User
  • Male
  • Female

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevalence of Central Precocious Puberty (CCP)
    • 3.3. Market Challenges
      • 3.3.1. Market Penetration Across New Regions
      • 3.3.2. Regulatory Approval
    • 3.4. Market Trends
      • 3.4.1. High Investment in Pharmaceutical R&D
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Histrelin, by End Use, Distribution, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Histrelin (Value)
      • 5.2.1. Global Histrelin by: End Use (Value)
        • 5.2.1.1. Hospitals
        • 5.2.1.2. Specialty Clinics
      • 5.2.2. Global Histrelin by: Distribution (Value)
        • 5.2.2.1. Hospital Dispensaries
        • 5.2.2.2. Online Third-Party Sales
      • 5.2.3. Global Histrelin by: End User (Value)
        • 5.2.3.1. Male
        • 5.2.3.2. Female
      • 5.2.4. Global Histrelin Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Histrelin: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Endo International plc (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
  • 7. Global Histrelin Sale, by End Use, Distribution, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Histrelin (Value)
      • 7.2.1. Global Histrelin by: End Use (Value)
        • 7.2.1.1. Hospitals
        • 7.2.1.2. Specialty Clinics
      • 7.2.2. Global Histrelin by: Distribution (Value)
        • 7.2.2.1. Hospital Dispensaries
        • 7.2.2.2. Online Third-Party Sales
      • 7.2.3. Global Histrelin by: End User (Value)
        • 7.2.3.1. Male
        • 7.2.3.2. Female
      • 7.2.4. Global Histrelin Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Histrelin: by End Use(USD Million)
  • Table 2. Histrelin Hospitals , by Region USD Million (2015-2020)
  • Table 3. Histrelin Specialty Clinics , by Region USD Million (2015-2020)
  • Table 4. Histrelin: by Distribution(USD Million)
  • Table 5. Histrelin Hospital Dispensaries , by Region USD Million (2015-2020)
  • Table 6. Histrelin Online Third-Party Sales , by Region USD Million (2015-2020)
  • Table 7. Histrelin: by End User(USD Million)
  • Table 8. Histrelin Male , by Region USD Million (2015-2020)
  • Table 9. Histrelin Female , by Region USD Million (2015-2020)
  • Table 10. South America Histrelin, by Country USD Million (2015-2020)
  • Table 11. South America Histrelin, by End Use USD Million (2015-2020)
  • Table 12. South America Histrelin, by Distribution USD Million (2015-2020)
  • Table 13. South America Histrelin, by End User USD Million (2015-2020)
  • Table 14. Brazil Histrelin, by End Use USD Million (2015-2020)
  • Table 15. Brazil Histrelin, by Distribution USD Million (2015-2020)
  • Table 16. Brazil Histrelin, by End User USD Million (2015-2020)
  • Table 17. Argentina Histrelin, by End Use USD Million (2015-2020)
  • Table 18. Argentina Histrelin, by Distribution USD Million (2015-2020)
  • Table 19. Argentina Histrelin, by End User USD Million (2015-2020)
  • Table 20. Rest of South America Histrelin, by End Use USD Million (2015-2020)
  • Table 21. Rest of South America Histrelin, by Distribution USD Million (2015-2020)
  • Table 22. Rest of South America Histrelin, by End User USD Million (2015-2020)
  • Table 23. Asia Pacific Histrelin, by Country USD Million (2015-2020)
  • Table 24. Asia Pacific Histrelin, by End Use USD Million (2015-2020)
  • Table 25. Asia Pacific Histrelin, by Distribution USD Million (2015-2020)
  • Table 26. Asia Pacific Histrelin, by End User USD Million (2015-2020)
  • Table 27. China Histrelin, by End Use USD Million (2015-2020)
  • Table 28. China Histrelin, by Distribution USD Million (2015-2020)
  • Table 29. China Histrelin, by End User USD Million (2015-2020)
  • Table 30. Japan Histrelin, by End Use USD Million (2015-2020)
  • Table 31. Japan Histrelin, by Distribution USD Million (2015-2020)
  • Table 32. Japan Histrelin, by End User USD Million (2015-2020)
  • Table 33. India Histrelin, by End Use USD Million (2015-2020)
  • Table 34. India Histrelin, by Distribution USD Million (2015-2020)
  • Table 35. India Histrelin, by End User USD Million (2015-2020)
  • Table 36. South Korea Histrelin, by End Use USD Million (2015-2020)
  • Table 37. South Korea Histrelin, by Distribution USD Million (2015-2020)
  • Table 38. South Korea Histrelin, by End User USD Million (2015-2020)
  • Table 39. Taiwan Histrelin, by End Use USD Million (2015-2020)
  • Table 40. Taiwan Histrelin, by Distribution USD Million (2015-2020)
  • Table 41. Taiwan Histrelin, by End User USD Million (2015-2020)
  • Table 42. Australia Histrelin, by End Use USD Million (2015-2020)
  • Table 43. Australia Histrelin, by Distribution USD Million (2015-2020)
  • Table 44. Australia Histrelin, by End User USD Million (2015-2020)
  • Table 45. Rest of Asia-Pacific Histrelin, by End Use USD Million (2015-2020)
  • Table 46. Rest of Asia-Pacific Histrelin, by Distribution USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Histrelin, by End User USD Million (2015-2020)
  • Table 48. Europe Histrelin, by Country USD Million (2015-2020)
  • Table 49. Europe Histrelin, by End Use USD Million (2015-2020)
  • Table 50. Europe Histrelin, by Distribution USD Million (2015-2020)
  • Table 51. Europe Histrelin, by End User USD Million (2015-2020)
  • Table 52. Germany Histrelin, by End Use USD Million (2015-2020)
  • Table 53. Germany Histrelin, by Distribution USD Million (2015-2020)
  • Table 54. Germany Histrelin, by End User USD Million (2015-2020)
  • Table 55. France Histrelin, by End Use USD Million (2015-2020)
  • Table 56. France Histrelin, by Distribution USD Million (2015-2020)
  • Table 57. France Histrelin, by End User USD Million (2015-2020)
  • Table 58. Italy Histrelin, by End Use USD Million (2015-2020)
  • Table 59. Italy Histrelin, by Distribution USD Million (2015-2020)
  • Table 60. Italy Histrelin, by End User USD Million (2015-2020)
  • Table 61. United Kingdom Histrelin, by End Use USD Million (2015-2020)
  • Table 62. United Kingdom Histrelin, by Distribution USD Million (2015-2020)
  • Table 63. United Kingdom Histrelin, by End User USD Million (2015-2020)
  • Table 64. Netherlands Histrelin, by End Use USD Million (2015-2020)
  • Table 65. Netherlands Histrelin, by Distribution USD Million (2015-2020)
  • Table 66. Netherlands Histrelin, by End User USD Million (2015-2020)
  • Table 67. Rest of Europe Histrelin, by End Use USD Million (2015-2020)
  • Table 68. Rest of Europe Histrelin, by Distribution USD Million (2015-2020)
  • Table 69. Rest of Europe Histrelin, by End User USD Million (2015-2020)
  • Table 70. MEA Histrelin, by Country USD Million (2015-2020)
  • Table 71. MEA Histrelin, by End Use USD Million (2015-2020)
  • Table 72. MEA Histrelin, by Distribution USD Million (2015-2020)
  • Table 73. MEA Histrelin, by End User USD Million (2015-2020)
  • Table 74. Middle East Histrelin, by End Use USD Million (2015-2020)
  • Table 75. Middle East Histrelin, by Distribution USD Million (2015-2020)
  • Table 76. Middle East Histrelin, by End User USD Million (2015-2020)
  • Table 77. Africa Histrelin, by End Use USD Million (2015-2020)
  • Table 78. Africa Histrelin, by Distribution USD Million (2015-2020)
  • Table 79. Africa Histrelin, by End User USD Million (2015-2020)
  • Table 80. North America Histrelin, by Country USD Million (2015-2020)
  • Table 81. North America Histrelin, by End Use USD Million (2015-2020)
  • Table 82. North America Histrelin, by Distribution USD Million (2015-2020)
  • Table 83. North America Histrelin, by End User USD Million (2015-2020)
  • Table 84. United States Histrelin, by End Use USD Million (2015-2020)
  • Table 85. United States Histrelin, by Distribution USD Million (2015-2020)
  • Table 86. United States Histrelin, by End User USD Million (2015-2020)
  • Table 87. Canada Histrelin, by End Use USD Million (2015-2020)
  • Table 88. Canada Histrelin, by Distribution USD Million (2015-2020)
  • Table 89. Canada Histrelin, by End User USD Million (2015-2020)
  • Table 90. Mexico Histrelin, by End Use USD Million (2015-2020)
  • Table 91. Mexico Histrelin, by Distribution USD Million (2015-2020)
  • Table 92. Mexico Histrelin, by End User USD Million (2015-2020)
  • Table 93. Company Basic Information, Sales Area and Its Competitors
  • Table 94. Histrelin: by End Use(USD Million)
  • Table 95. Histrelin Hospitals , by Region USD Million (2021-2026)
  • Table 96. Histrelin Specialty Clinics , by Region USD Million (2021-2026)
  • Table 97. Histrelin: by Distribution(USD Million)
  • Table 98. Histrelin Hospital Dispensaries , by Region USD Million (2021-2026)
  • Table 99. Histrelin Online Third-Party Sales , by Region USD Million (2021-2026)
  • Table 100. Histrelin: by End User(USD Million)
  • Table 101. Histrelin Male , by Region USD Million (2021-2026)
  • Table 102. Histrelin Female , by Region USD Million (2021-2026)
  • Table 103. South America Histrelin, by Country USD Million (2021-2026)
  • Table 104. South America Histrelin, by End Use USD Million (2021-2026)
  • Table 105. South America Histrelin, by Distribution USD Million (2021-2026)
  • Table 106. South America Histrelin, by End User USD Million (2021-2026)
  • Table 107. Brazil Histrelin, by End Use USD Million (2021-2026)
  • Table 108. Brazil Histrelin, by Distribution USD Million (2021-2026)
  • Table 109. Brazil Histrelin, by End User USD Million (2021-2026)
  • Table 110. Argentina Histrelin, by End Use USD Million (2021-2026)
  • Table 111. Argentina Histrelin, by Distribution USD Million (2021-2026)
  • Table 112. Argentina Histrelin, by End User USD Million (2021-2026)
  • Table 113. Rest of South America Histrelin, by End Use USD Million (2021-2026)
  • Table 114. Rest of South America Histrelin, by Distribution USD Million (2021-2026)
  • Table 115. Rest of South America Histrelin, by End User USD Million (2021-2026)
  • Table 116. Asia Pacific Histrelin, by Country USD Million (2021-2026)
  • Table 117. Asia Pacific Histrelin, by End Use USD Million (2021-2026)
  • Table 118. Asia Pacific Histrelin, by Distribution USD Million (2021-2026)
  • Table 119. Asia Pacific Histrelin, by End User USD Million (2021-2026)
  • Table 120. China Histrelin, by End Use USD Million (2021-2026)
  • Table 121. China Histrelin, by Distribution USD Million (2021-2026)
  • Table 122. China Histrelin, by End User USD Million (2021-2026)
  • Table 123. Japan Histrelin, by End Use USD Million (2021-2026)
  • Table 124. Japan Histrelin, by Distribution USD Million (2021-2026)
  • Table 125. Japan Histrelin, by End User USD Million (2021-2026)
  • Table 126. India Histrelin, by End Use USD Million (2021-2026)
  • Table 127. India Histrelin, by Distribution USD Million (2021-2026)
  • Table 128. India Histrelin, by End User USD Million (2021-2026)
  • Table 129. South Korea Histrelin, by End Use USD Million (2021-2026)
  • Table 130. South Korea Histrelin, by Distribution USD Million (2021-2026)
  • Table 131. South Korea Histrelin, by End User USD Million (2021-2026)
  • Table 132. Taiwan Histrelin, by End Use USD Million (2021-2026)
  • Table 133. Taiwan Histrelin, by Distribution USD Million (2021-2026)
  • Table 134. Taiwan Histrelin, by End User USD Million (2021-2026)
  • Table 135. Australia Histrelin, by End Use USD Million (2021-2026)
  • Table 136. Australia Histrelin, by Distribution USD Million (2021-2026)
  • Table 137. Australia Histrelin, by End User USD Million (2021-2026)
  • Table 138. Rest of Asia-Pacific Histrelin, by End Use USD Million (2021-2026)
  • Table 139. Rest of Asia-Pacific Histrelin, by Distribution USD Million (2021-2026)
  • Table 140. Rest of Asia-Pacific Histrelin, by End User USD Million (2021-2026)
  • Table 141. Europe Histrelin, by Country USD Million (2021-2026)
  • Table 142. Europe Histrelin, by End Use USD Million (2021-2026)
  • Table 143. Europe Histrelin, by Distribution USD Million (2021-2026)
  • Table 144. Europe Histrelin, by End User USD Million (2021-2026)
  • Table 145. Germany Histrelin, by End Use USD Million (2021-2026)
  • Table 146. Germany Histrelin, by Distribution USD Million (2021-2026)
  • Table 147. Germany Histrelin, by End User USD Million (2021-2026)
  • Table 148. France Histrelin, by End Use USD Million (2021-2026)
  • Table 149. France Histrelin, by Distribution USD Million (2021-2026)
  • Table 150. France Histrelin, by End User USD Million (2021-2026)
  • Table 151. Italy Histrelin, by End Use USD Million (2021-2026)
  • Table 152. Italy Histrelin, by Distribution USD Million (2021-2026)
  • Table 153. Italy Histrelin, by End User USD Million (2021-2026)
  • Table 154. United Kingdom Histrelin, by End Use USD Million (2021-2026)
  • Table 155. United Kingdom Histrelin, by Distribution USD Million (2021-2026)
  • Table 156. United Kingdom Histrelin, by End User USD Million (2021-2026)
  • Table 157. Netherlands Histrelin, by End Use USD Million (2021-2026)
  • Table 158. Netherlands Histrelin, by Distribution USD Million (2021-2026)
  • Table 159. Netherlands Histrelin, by End User USD Million (2021-2026)
  • Table 160. Rest of Europe Histrelin, by End Use USD Million (2021-2026)
  • Table 161. Rest of Europe Histrelin, by Distribution USD Million (2021-2026)
  • Table 162. Rest of Europe Histrelin, by End User USD Million (2021-2026)
  • Table 163. MEA Histrelin, by Country USD Million (2021-2026)
  • Table 164. MEA Histrelin, by End Use USD Million (2021-2026)
  • Table 165. MEA Histrelin, by Distribution USD Million (2021-2026)
  • Table 166. MEA Histrelin, by End User USD Million (2021-2026)
  • Table 167. Middle East Histrelin, by End Use USD Million (2021-2026)
  • Table 168. Middle East Histrelin, by Distribution USD Million (2021-2026)
  • Table 169. Middle East Histrelin, by End User USD Million (2021-2026)
  • Table 170. Africa Histrelin, by End Use USD Million (2021-2026)
  • Table 171. Africa Histrelin, by Distribution USD Million (2021-2026)
  • Table 172. Africa Histrelin, by End User USD Million (2021-2026)
  • Table 173. North America Histrelin, by Country USD Million (2021-2026)
  • Table 174. North America Histrelin, by End Use USD Million (2021-2026)
  • Table 175. North America Histrelin, by Distribution USD Million (2021-2026)
  • Table 176. North America Histrelin, by End User USD Million (2021-2026)
  • Table 177. United States Histrelin, by End Use USD Million (2021-2026)
  • Table 178. United States Histrelin, by Distribution USD Million (2021-2026)
  • Table 179. United States Histrelin, by End User USD Million (2021-2026)
  • Table 180. Canada Histrelin, by End Use USD Million (2021-2026)
  • Table 181. Canada Histrelin, by Distribution USD Million (2021-2026)
  • Table 182. Canada Histrelin, by End User USD Million (2021-2026)
  • Table 183. Mexico Histrelin, by End Use USD Million (2021-2026)
  • Table 184. Mexico Histrelin, by Distribution USD Million (2021-2026)
  • Table 185. Mexico Histrelin, by End User USD Million (2021-2026)
  • Table 186. Research Programs/Design for This Report
  • Table 187. Key Data Information from Secondary Sources
  • Table 188. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Histrelin: by End Use USD Million (2015-2020)
  • Figure 5. Global Histrelin: by Distribution USD Million (2015-2020)
  • Figure 6. Global Histrelin: by End User USD Million (2015-2020)
  • Figure 7. South America Histrelin Share (%), by Country
  • Figure 8. Asia Pacific Histrelin Share (%), by Country
  • Figure 9. Europe Histrelin Share (%), by Country
  • Figure 10. MEA Histrelin Share (%), by Country
  • Figure 11. North America Histrelin Share (%), by Country
  • Figure 12. Global Histrelin share by Players 2020 (%)
  • Figure 13. BCG Matrix for key Companies
  • Figure 14. Endo International plc (United States) Revenue, Net Income and Gross profit
  • Figure 15. Endo International plc (United States) Revenue: by Geography 2020
  • Figure 16. Global Histrelin: by End Use USD Million (2021-2026)
  • Figure 17. Global Histrelin: by Distribution USD Million (2021-2026)
  • Figure 18. Global Histrelin: by End User USD Million (2021-2026)
  • Figure 19. South America Histrelin Share (%), by Country
  • Figure 20. Asia Pacific Histrelin Share (%), by Country
  • Figure 21. Europe Histrelin Share (%), by Country
  • Figure 22. MEA Histrelin Share (%), by Country
  • Figure 23. North America Histrelin Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Endo International plc (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation